Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Investigative Dermatology

• Publication date

  2012-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/jid.2012.233PMID 22832492
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fisetin: a natural fist against melanoma?

  2011cited by this paper
• CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity.

  2011cited by this paper
• Polo-like kinase 1 is a potential therapeutic target in human melanoma.

  2011cited by this paper
• Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

  2010cited by this paper
• ERK and cell death: Mechanisms of ERK‐induced cell death – apoptosis, autophagy and senescence

  2010cited by this paper
• Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

  2010cited by this paper
• Mdm2-mediated ubiquitylation: p53 and beyond

  2010cited by this paper
• PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.

  2010cited by this paper
• Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis

  2010cited by this paper
• Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K.

  2010cited by this paper
• Inhibition of mutated, activated BRAF in metastatic melanoma.

  2010cited by this paper
• Prognostic value of CRM1in pancreas cancer

  2009cited by this paper
• Identification of nuclear export inhibitors with potent anticancer activity in vivo.

  2009cited by this paper
• The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation

  2009cited by this paper
• EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS

  2009cited by this paper
• Prognostic value of CRM1 in pancreas cancer.

  2009cited by this paper
• Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma.

  2008cited by this paper
• CRM1-mediated nuclear export of proteins and drug resistance in cancer.

  2008cited by this paper
• Anticancer therapy: boosting the bang of Bim.

  2008cited by this paper
• Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer

  2008cited by this paper
• Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma Metastases

  2008cited by this paper
• Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation

  2008cited by this paper
• Nuclear export is essential for the tumor‐promoting activity of survivin

  2007cited by this paper
• Rewired ERK-JNK signaling pathways in melanoma.

  2007cited by this paper
• Involvement of protein phosphatase 2A nuclear accumulation and subsequent inactivation of activator protein-1 in leptomycin B-inhibited cyclin D1 expression

  2007cited by this paper
• hPEBP4 Resists TRAIL-induced Apoptosis of Human Prostate Cancer Cells by Activating Akt and Deactivating ERK1/2 Pathways*

  2007cited by this paper
• RSK and MSK in MAP kinase signalling

  2006cited by this paper
• The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions

  2006cited by this paper
• Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

  2005cited by this paper
• Cytoplasmic retention of peroxide‐activated ERK provides survival in primary cultures of rat hepatocytes

  2005cited by this paper
• Recurrent patterns of dual RB and p53 pathway inactivation in melanoma.

  2005cited by this paper
• Nuclear transport and cancer: from mechanism to intervention

  2004cited by this paper
• Subcellular Localization Determines the Protective Effects of Activated ERK2 against Distinct Apoptogenic Stimuli in Myeloid Leukemia Cells*

  2004cited by this paper
• Sef is a spatial regulator for Ras/MAP kinase signaling.

  2004cited by this paper
• Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell line

  2003cited by this paper
• NESbase version 1.0: a database of nuclear export signals

  2003cited by this paper
• CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin.

  2002cited by this paper
• The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.

  2002cited by this paper
• Nucleocytoplasmic transport: Ran, beta and beyond.

  2001cited by this paper
• Inhibition of melanoma tumor growth in vivo by survivin targeting.

  2001cited by this paper
• Genomic analysis of metastasis reveals an essential role for RhoC

  2000cited by this paper
• Nuclear Export of Map Kinase (ERK) Involves a Map Kinase Kinase (Mek-Dependent) Active Transport Mechanism

  2000cited by this paper
• ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.

  2000cited by this paper
• The Mammalian Mog1 Protein Is a Guanine Nucleotide Release Factor for Ran*

  2000cited by this paper
• A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals.

  2000cited by this paper
• Effects on normal fibroblasts and neuroblastoma cells of the activation of the p53 response by the nuclear export inhibitor leptomycin B

  1999cited by this paper
• Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.

  1999cited by this paper
• A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking

  1999cited by this paper
• Differential regulation of c‐Jun by ERK and JNK during PC12 cell differentiation

  1998cited by this paper
• Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6

  1998cited by this paper
• Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA.

  1997cited by this paper
• Cytoplasmic Localization of Mitogen-activated Protein Kinase Kinase Directed by Its NH2-terminal, Leucine-rich Short Amino Acid Sequence, Which Acts as a Nuclear Export Signal*

  1996cited by this paper
• Identification of a signal for rapid export of proteins from the nucleus.

  1995cited by this paper
• The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain.

  1993cited by this paper

• Targeted therapies reshape extracellular matrix remodeling and microenvironmental regulation in pediatric acute myeloid leukemia.

  2026cites this paper
• Homeostatic regulation of nucleoporins is a central driver of nuclear pore biogenesis

  2025cites this paper
• Cracking melanoma’s armor: Supramolecular dual-strike on XPO1 and β-catenin to overcome resistance

  2025cites this paper
• RANBP1 (RAN Binding Protein 1): The Missing Genetic Piece in Cancer Pathophysiology and Other Complex Diseases

  2023cites this paper
• ACAGT‐007a, an anti‐cancer compound that modulates ERK MAPK signaling, induces nuclear enrichment of phosphorylated ERK in T3M4 pancreatic cancer cells

  2023influential citation
• One Stone, Two Birds: A Peptide-Au(I) Infinite Coordination Supermolecule for the Confederate Physical and Biological Radiosensitization in Cancer Radiation Therapy.

  2022cites this paper
• RanBP3 Regulates Proliferation, Apoptosis and Chemosensitivity of Chronic Myeloid Leukemia Cells via Mediating SMAD2/3 and ERK1/2 Nuclear Transport

  2021cites this paper
• New Insights into the Link between Melanoma and Thyroid Cancer: Role of Nucleocytoplasmic Trafficking

  2021cites this paper
• Inhibition of Nuclear Pore Complex Formation Selectively Induces Cancer Cell Death.

  2020cites this paper
• NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors

  2020cites this paper
• Proteostasis unbalance of nucleophosmin 1 in Acute Myeloid Leukemia: An aggregomic perspective.

  2020cites this paper
• Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness

  2020cites this paper
• The past, present, and future of CRM1/XPO1 inhibitors.

  2019cites this paper
• Nucleocytoplasmic p27Kip1 Export Is Required for ERK1/2-Mediated Reactive Astroglial Proliferation Following Status Epilepticus

  2018cites this paper
• Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death

  2018cites this paper
• Hitting a moving target: inhibition of the nuclear export receptor XPO1/CRM1 as a therapeutic approach in cancer

  2018cites this paper
• Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells

  2017influential citation
• RETRACTED ARTICLE: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin

  2017cites this paper
• Visualization of RAS/MAPK Signaling In Situ by the Proximity Ligation Assay (PLA).

  2017cites this paper
• Leptomycin B attenuates neuronal death via PKA- and PP2B-mediated ERK1/2 activation in the rat hippocampus following status epilepticus.

  2017cites this paper
• Chromosome region maintenance-1 (CRM1) regulates apoptosis of intestinal epithelial cells via p27kip1 in Crohn's disease.

  2017cites this paper
• Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors

  2016cites this paper
• Role of RAGE in melanoma development, growth, and progression

  2016cites this paper
• Investigating a novel small molecule inhibitor of nuclear import as an anti-cancer approach

  2016cites this paper
• Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT‐330): A report from the pediatric preclinical testing program

  2016cites this paper
• Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic

  2016cites this paper
• RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear Export.

  2016cites this paper
• Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells

  2016cites this paper
• A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K

  2016cites this paper
• Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcoma

  2016cites this paper
• Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer

  2016cites this paper
• RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear Export.

  2015influential citation
• A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds

  2015cites this paper
• Structural Basis of Targeting the Exportin CRM1 in Cancer

  2015cites this paper
• Caractérisation d'anomalies cytogénétiques et moléculaires dans la leucémie lymphoïde chronique

  2015cites this paper
• Ran signaling in melanoma: implications for the development of alternative therapeutic strategies.

  2015cites this paper
• Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds

  2015cites this paper
• The Cellular Distribution of RanGAP1 Is Regulated by CRM1-Mediated Nuclear Export in Mammalian Cells

  2015cites this paper
• Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins.

  2014cites this paper
• SINE (selective inhibitor of nuclear export) – translational science in a new class of anti-cancer agents

  2014cites this paper
• Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents.

  2014cites this paper
• Biological Significance of the Importin‐β Family‐Dependent Nucleocytoplasmic Transport Pathways

  2014cites this paper
• Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents

  2014cites this paper
• Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines

  2014cites this paper
• Clinical translation of nuclear export inhibitors in cancer.

  2014cites this paper
• CRM1 is a direct cellular target of the natural anti-cancer agent plumbagin.

  2014cites this paper
• Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic

  2014cites this paper
• Biologic Activity of the Novel SINE Compound KPT-335 Against Canine Melanoma Cell Lines

  2014cites this paper
• KPT-330 has antitumour activity against non-small cell lung cancer

  2014cites this paper
• Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells

  2014influential citation
• CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma

  2013influential citation